NDC product
GoLYTELY
NDC 52268-100 · Braintree Laboratories, Inc.
Key facts
| Product NDC | 52268-100 |
|---|---|
| Proprietary name | GoLYTELY |
| Nonproprietary name | Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride |
| Substances | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE |
| Dosage form | POWDER, FOR SOLUTION |
| Route | ORAL |
| Labeler | Braintree Laboratories, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA019011 |
| Pharmacologic classes | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC] and 1 more |
| Marketing start | Jul 13, 1984 |
| Marketing end | Mar 31, 2030 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory